Thursday, March 22, 2018

Kaneka Eurogentec Announces the Construction of a New Large Scale Pharmaceutical Grade Biologics Manufacturing Facility
  SocialTwist Tell-a-Friend  

Date: 13-09-2017 12:25PM
Source: Kaneka Eurogentec
Category: Business/ Finance, Pharmaceutical, General, Science & Research, Healthcare & Biotechnology, Major Diversified Industrial Groups, Manufacturing Companies
Location: Seraing, Belgium

Business Wire India

Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), announced that its board has approved the construction of a new state of-the-art GMP facility adjacent to its current facility and equipped with a 2200 L fermenter. The expansion will allow for the large scale production of biopharmaceuticals including recombinant proteins, antibody fragments and plasmid DNA.

A new facility responding to current market needs

The multi-product facility will include the capability for large scale production using innovative Eurogentec technologies such as the improved production of complex proteins by secretion from yeasts and the production of kilo-scale plasmid DNA for viral and non-viral gene and cell therapies. This expansion will be complementary to the current capabilities and together will provide small and industrial scale production. It will offer on a single site to clients on a worldwide basis biologics manufacturing intended to clinical studies and commercialization.

Lieven Janssens, Executive Vice President at Kaneka Eurogentec stated “The rapid growth in cell and gene therapy products is driving the need for large batches of plasmid DNA; our existing pharma and biotech customers have already expressed the need for kilo-scale manufacturing capabilities and we have developed equipment and methods to respond to these needs with the new facility”.

Ingrid Dheur, Vice President Biologics at Kaneka Eurogentec added “Complex protein structures such as new antibody formats are generating rapid growth in the use of Pichia pastoris for these types of biologics; the new facility will also be equipped for large scale production using such yeast expression systems”.

Construction is expected to start in autumn of 2017. The state-of-the-art facility will be equipped for the production and purification of new biomedicines using cost-effective and safe microbial strains and will include the installation of a 2200 L fermenter, harvest and purification equipment for all expression strategies. Additionally, the expansion will result in the hiring of 40 full time scientific staff trained in the production of GMP therapeutic products.

About Kaneka Eurogentec

Eurogentec was founded in 1985 as a spin-off company of the University of Liège (Belgium). Kaneka Eurogentec contributes to improving health and fighting diseases by supplying products and services to scientists involved in life science research, molecular diagnostics, and therapeutic developments. The Liège-based company is recognised as one of the major suppliers in the field of genomics and proteomics as well as a trusted Contract Development and Manufacturing Organisation (CDMO) for the bio-production of pharmaceuticals (vaccines and medicines

In 2010, Eurogentec, renamed Kaneka Eurogentec in April 2017, became part of Kaneka Corporation, a large Japanese chemical company focusing on technology and innovation.

About Kaneka Corporation

Kaneka is an innovation-oriented chemical company. Traditionally the company has been active in polymers, fermentation, biotechnology and electronics, as well as other fields. Business activities now span a broad spectrum of markets ranging from plastics, EPS resins, chemicals and foodstuffs to pharmaceuticals, medical devices, electrical and electronic materials and synthetic fibers. The life science related activities are currently one of the strategically important domains for Kaneka. The company has been a pioneer among Japanese chemical companies in establishing overseas operations, beginning in 1970 with a subsidiary in Belgium.


Kaneka Eurogentec S.A.
Pascal Bolon, Tel: +32 4 366 61 16
Biologics Sales-Marketing Manager

More Press Releases

GSMA Advances a Comprehensive Agenda on Digital Inclusion for Women Ahead of G20 Summit

Philip Morris International Shifts Entire Capacity of Its Cigarette Factory in Greece to Smoke-Free Products

Recipients for 12th GATSBY CREATIVE AWARDS Decided

BIRAC and PerkinElmer Sign Letter of Intent to Promote India-Led Startups and Innovations

Gemalto Unveils Two New Enhanced Security Features for ID Documents

Bentley Systems' Year in Infrastructure 2018 Conference and Awards Gala to be Held in London, Oct. 15-18

Dubai Breaks Ground on World’s Biggest CSP Project

DHFL Pramerica AMC Appoints Rajesh Iyer as CEO

Morinaga Milk's New Probiotic Strain, Bifidobacterium breve A1, May Prevent Onset of Alzheimer's Disease

Chitkara University Professor Achieves Honours at Economic Times – Power of Ideas 2018

Accenture Labs and Grameen Foundation India Use Emerging Technologies to Help Increase Adoption of Financial Services Among Low-income Women

Technics Organizes World's First Full Turntable Orchestra

Edgecore Networks Introduces 400G Open Networking

Telangana's Biggest National Rural Technology Festival 'Antahpragnya 2018' kicked off at RGUKT, Basar

Chargebee Closes Series C with $18 Million Investment from Insight Venture Partners

Rolls-Royce Motor Cars Announces the Silver Ghost Collection

FLIR Launches Thermal Traffic Sensor for Vehicle-to-Everything Communication

IDEMIA: Easier Travel with the Biometric Innovations Presented at Passenger Terminal Expo (20–22 March 2018)

Toshiba Memory Corporation Releases Enhanced Data Center SSD Line-up with 64-Layer 3D Flash Memory

MIPAQ™ Pro, the Intelligent Device for Smart Grids

Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed in large prospective real-world analysis

Louis Chevrolet Watch Company launches the Chrono-Tour Bitcoin Special Edition

Shopping on Instagram Goes Global with Shopify

Prof. Frank Stangnberg-Haverkamp Meets the President of Niger H.E. Mahamadou Issoufou to Discuss Merck Foundation Commitment towards Niger

FAA Approves AerTrakTM to Comply with Automatic Dependent Surveillance-Broadcast (ADS-B) Operations Mandate

Star Union Dai-ichi Life Insurance Co. Ltd. Partners with Manipal Global Education Services for a Customized Talent Development Program

New Documentary Raises Global Water Crisis Awareness As 844 Million People Still Lack Access to Clean Drinking Water

IDEMIA Partnering with Unisys to Provide Biometric Services for Home Affairs Department in Australia

Intuit’s Open Platform Strategy Transforms How QuickBooks Online Accountant Users Serve Their Clients

LEE Launches Spring Summer 2018 BODY OPTIX 360 Collection

New Global Survey Points to Key Issues, Needs and Gaps in Fight to End Smoking

Akshay Kumar Reveals that the Secret to his Son Aarav's Success May be a Very Special Lady!

Badminton Champ and Coach Pullella Gopichand Says he Struggles Between Being a Tough or Lenient Coach

Kent RO Teams Up with Kings XI Punjab as Title Sponsor

Bajaj Electricals Showcases 'Smart Indoors and Connected Outdoors' at Light + Building 2018

Priyadarshni Academy Celebrates 34th Anniversary Literary Awards and Educational Scholarships Program

L&T Technology Services' Industry Academia Skill Building Initiative TECHgium®, Receives Record Breaking Participation

HealthMode.Org Launches Window of Opportunity Drive and Free Public Service Live Chat on Website to Raise Awareness of Risk and Prevention of Chronic Lifestyle Diseases in India

Tripura to brand pineapple international...
Jackfruit declared as Kerala's official ...
Cricket-Thunderstorm helps West Indies t...
Shivpal attend SP dinner for RS Polls...
Shivpal ,Raja Bhaiyya attend SP dinner f...
PM congratulates Angela Merkel on assum...
 Top Stories
Peruvian President announces resign... 
Austin bomber left confession video... 
DHFL Pramerica AMC appoints Rajesh ... 
OPPLE attends Light and Building Fa... 
Angus Young writing new AC/DC album... 
Mark Zuckerberg apologises for data... 
US Congress unveils $1.3tn spending... 
'We Are Sikhs' campaign wins top US...